Momenta Pharmaceuticals Inc. Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Momenta Pharmaceuticals Inc.

MNTA 52.48

0.0%

Oct 2 5:00 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: fred hayes who wrote (2402)	8/6/2010 10:29:56 AM
From: Biotech Jim	Read Replies (2) of 3027

<for approving a second version that is not fully characterized> This in my opinion is a nonstarter and would only complicate approvals in the future. Just not possible, if you mean chemically characterized. Now in my opinion the use of co-polymer of peptides of input amino acid "ratios" is a different story where I have some doubts (ie copaxone). Will discuss that a bit more when I have more time. I have picked up some MNTA this morning. BJ

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next